These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 202413)

  • 1. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
    Tisdale MJ; Habberfield AD
    Biochem Pharmacol; 1980 Oct; 29(20):2845-53. PubMed ID: 7002161
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
    Mandel HG; Connors TA; Melzack DH; Merai K
    Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells.
    Mokashi S; Delikatny SJ; Orr FW
    Cancer Res; 1983 May; 43(5):1980-3. PubMed ID: 6299536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 11. Variations in cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate content and efflux from the photosensitive pineal organ of the pike in culture.
    Falcón J; Gaildrat P
    Pflugers Arch; 1997 Jan; 433(3):336-42. PubMed ID: 9064650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
    Roberts JJ; Friedlos F; Knox RJ
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):205-10. PubMed ID: 163093
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.
    Lalka D; Bardos TJ
    Biochem Pharmacol; 1975 Feb; 24(4):455-6. PubMed ID: 1167458
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycine receptor in hippocampal neurons as a target for action of extracellular cyclic nucleotides.
    Bukanova JV; Solntseva EI; Kondratenko RV; Skrebitsky VG
    Neurosci Lett; 2014 Feb; 561():58-63. PubMed ID: 24373992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent regulation of guanosine 3',5'-monophosphate in renal cortex: effects of ionophore A23187 and tetracaine and evidence for independent control of adenosine 3',5'-monophosphate.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Oct; 25(10):1113-27. PubMed ID: 184365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of cyclic nucleotides with proteins in malignant and adenosine cyclic 3':5'-monophosphate-induced "differentiated" neuroblastoma cells in culture.
    Prasad KN; Sinha PK; Sahu SK; Brown JL
    Cancer Res; 1976 Jul; 36(7 PT 1):2290-6. PubMed ID: 179701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An equilibrium study of the cooperative binding of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate to the adenosine cyclic 3',5'-monophosphate receptor protein from Escherichia coli.
    Takahashi M; Blazy B; Baudras A
    Biochemistry; 1980 Oct; 19(22):5124-30. PubMed ID: 6257276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.